Bessemer Group’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-110
Closed -$2K 2504
2024
Q4
$2K Hold
110
﹤0.01% 2200
2024
Q3
$3K Buy
+110
New +$3K ﹤0.01% 2079